Immuneering Corp. (IMRX)
4.07
+0.04
(+0.99%)
USD |
NASDAQ |
Oct 02, 16:00
4.07
0.00 (0.00%)
After-Hours: 20:00
Immuneering Market Cap : 263.32M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 263.32M |
| October 01, 2026 | 260.73M |
| September 30, 2026 | 264.94M |
| September 29, 2026 | 267.20M |
| September 28, 2026 | 269.14M |
| September 25, 2026 | 276.26M |
| September 24, 2026 | 280.79M |
| September 23, 2026 | 283.37M |
| September 22, 2026 | 298.26M |
| September 21, 2026 | 287.26M |
| September 18, 2026 | 289.84M |
| September 17, 2026 | 288.55M |
| September 16, 2026 | 287.90M |
| September 15, 2026 | 287.26M |
| September 14, 2026 | 280.14M |
| September 11, 2026 | 276.26M |
| September 10, 2026 | 295.67M |
| September 09, 2026 | 298.26M |
| September 08, 2026 | 309.25M |
| September 04, 2026 | 311.84M |
| September 03, 2026 | 326.07M |
| September 02, 2026 | 324.78M |
| September 01, 2026 | 313.78M |
| August 31, 2026 | 322.84M |
| August 28, 2026 | 322.84M |
| Date | Value |
|---|---|
| August 27, 2026 | 337.07M |
| August 26, 2026 | 333.19M |
| August 25, 2026 | 338.37M |
| August 24, 2026 | 335.13M |
| August 21, 2026 | 342.90M |
| August 20, 2026 | 339.66M |
| August 19, 2026 | 344.84M |
| August 18, 2026 | 325.43M |
| August 17, 2026 | 337.72M |
| August 14, 2026 | 327.37M |
| August 13, 2026 | 336.43M |
| August 12, 2026 | 328.02M |
| August 11, 2026 | 310.55M |
| August 10, 2026 | 293.08M |
| August 07, 2026 | 291.79M |
| August 06, 2026 | 288.55M |
| August 05, 2026 | 284.02M |
| August 04, 2026 | 284.67M |
| August 03, 2026 | 269.79M |
| July 31, 2026 | 267.17M |
| July 30, 2026 | 273.63M |
| July 29, 2026 | 262.31M |
| July 28, 2026 | 274.28M |
| July 27, 2026 | 282.04M |
| July 24, 2026 | 279.46M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.434B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Savara, Inc. | 987.97M |
| Vericel Corp. | 2.055B |
| Biogen, Inc. | 32.48B |
Market Cap Related Metrics
| Price to Book Value | 1.380 |
| Price | 4.07 |
| Earnings Yield | -25.35% |